This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Université De Lille 2 Droit Et Santé. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 65 
2 out of 1,853 
2 out of 13 Years Active: 2018-2019
Title: The Innovative Journey of Nathalie Hennuyer
Introduction: Nathalie Hennuyer, an accomplished inventor based in Corbehem, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of two patents, she is recognized for her innovative solutions and dedication to improving health outcomes.
Latest Patents: Hennuyer's most recent patents showcase her expertise in developing novel compounds. The first patent, titled "Imidazol- or 1,2,4-triazol-derivatives and their use," is directed at unique compounds that could play a vital role in pharmaceutical applications. The second patent, "2-oxo-3,4-dihydropyridine-5-carboxylates and their use," introduces additional novel compounds, further demonstrating her commitment to advancing medicinal chemistry.
Career Highlights: Nathalie has held positions at esteemed institutions such as Université de Lille 2 Droit et Santé and Institut Pasteur de Lille. Her work in these organizations has laid a strong foundation for her innovative research and development efforts in the pharmaceutical sector.
Collaborations: Throughout her career, Hennuyer has collaborated with fellow researchers, including Julie Charton and Benoit Deprez. These professional relationships have enabled her to leverage collective expertise and foster an environment of innovation.
Conclusion: Nathalie Hennuyer's dedication to advancing pharmaceutical science through her patents and research exemplifies her role as a leading inventor. Her work continues to impact the medical field positively, and her contributions are a testament to the power of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile